Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma

Title
Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma
Authors
Keywords
DLBCL, rituximab, immunogenic cell death, HMGB1, STAT3
Journal
Oncotarget
Volume 6, Issue 29, Pages -
Publisher
Impact Journals, LLC
Online
2015-09-30
DOI
10.18632/oncotarget.4816

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started